Spain
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.56 B
|
Dec. 31, 2023 | USD 9.29 | 3.24% |
|
Spain |
|
2 |
USD 636.99 M
|
Dec. 31, 2023 | USD 8.60 | 3.71% |
|
Spain |
|
3 |
USD 163.95 M
|
Dec. 31, 2023 | USD 77.86 | 1.89% |
|
Spain |
|
4 |
USD 156.48 M
|
Dec. 31, 2023 | USD 3.66 | 0.89% |
|
Spain |
|
5 |
USD 28.59 M
|
Dec. 31, 2023 | USD 1.87 | 1.16% |
|
Spain |
|
6 |
USD 15.40 M
|
Dec. 31, 2023 | USD 1.51 | -0.07% |
|
Spain |
|
7 |
USD 8.56 M
|
Dec. 31, 2023 | USD 1.80 | 0.04% |
|
Spain |
The Biotechnology company in Spain with the highest Gross Profit is Grifols, S.A. (MCE: GRF.MC) at USD 2.56 B.
The Biotechnology company in Spain with the lowest Gross Profit is Pangaea Oncology, S.A. (MCE: PANG.MC) at USD 8.56 M.
The top 10 Biotechnology companies in Spain by Gross Profit are Grifols, S.A., Almirall, S.A., Pharma Mar, S.A., Atrys Health, S.A., Facephi Biometria, S.A., Oryzon Genomics S.A. and Pangaea Oncology, S.A..
The bottom 10 Biotechnology companies in Spain by Gross Profit are Pangaea Oncology, S.A., Oryzon Genomics S.A., Facephi Biometria, S.A., Atrys Health, S.A., Pharma Mar, S.A., Almirall, S.A. and Grifols, S.A..